These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 234219

  • 1. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ, Wasserman SI, Austen F.
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [Abstract] [Full Text] [Related]

  • 2. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ.
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [Abstract] [Full Text] [Related]

  • 3. The immunological basis of immediate hypersensitivity.
    Cooper DA.
    Aust Fam Physician; 1979 Jan; 8(1):38-9, 41-3, 45-6. PubMed ID: 86347
    [Abstract] [Full Text] [Related]

  • 4. Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function.
    Geotzl EJ, Austen KF.
    Monogr Allergy; 1977 Jan; 12():189-97. PubMed ID: 335214
    [No Abstract] [Full Text] [Related]

  • 5. The release of four mediators of immediate hypersensitivity from human leukemic basophils.
    Lewis RA, Goetzl EJ, Wasserman SI, Valone FH, Rubin RH, Austen KF.
    J Immunol; 1975 Jan; 114(1 Pt 1):87-92. PubMed ID: 46247
    [Abstract] [Full Text] [Related]

  • 6. Urticaria, angioedema, and mediator release in humans in response to physical environmental stimuli.
    Soter NA, Austen F.
    Fed Proc; 1977 Apr; 36(5):1736-41. PubMed ID: 844616
    [Abstract] [Full Text] [Related]

  • 7. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue.
    Austen KF.
    Fed Proc; 1974 Nov; 33(11):2256-62. PubMed ID: 4139041
    [No Abstract] [Full Text] [Related]

  • 8. [Mediators of the allergic reaction. Slow reacting substance (SRS-A)].
    Naranjo P.
    Allergol Immunopathol (Madr); 1975 Nov; 3(4):239-54. PubMed ID: 5879
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase.
    Wasserman SI, Goetzl EJ, Austen KF.
    J Immunol; 1975 Feb; 114(2 Pt 1):645-9. PubMed ID: 235589
    [Abstract] [Full Text] [Related]

  • 10. Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system.
    Kay AB.
    Antibiot Chemother (1971); 1974 Feb; 19():271-83. PubMed ID: 4142850
    [No Abstract] [Full Text] [Related]

  • 11. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.
    Soter NA, Wasserman SI, Austen KF.
    N Engl J Med; 1976 Mar 25; 294(13):687-90. PubMed ID: 55969
    [Abstract] [Full Text] [Related]

  • 12. [Structure and function of the eosinophil leucocytes (author's transl)].
    König W.
    Immun Infekt; 1978 Jun 25; 6(3):97-105. PubMed ID: 207635
    [Abstract] [Full Text] [Related]

  • 13. Eosinophil leucocytes: recruitment, localization and function in immediate-type hypersensitivity.
    Kay AB.
    Monogr Allergy; 1977 Jun 25; 12():222-30. PubMed ID: 411026
    [No Abstract] [Full Text] [Related]

  • 14. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM, König W, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1978 Jun 25; 56(5):398-408. PubMed ID: 344231
    [Abstract] [Full Text] [Related]

  • 15. Mast cell-mediated reactions of host defense and tissue injury: the regulatory role of eosinophil polymorphonuclear leukocytes.
    Goetzl EJ.
    Inflammation; 1977 Sep 25; 2(3):239-56. PubMed ID: 617809
    [Abstract] [Full Text] [Related]

  • 16. Current concepts of immediate (reaginic) hypersensitivity.
    Evans R.
    Med Ann Dist Columbia; 1972 Jul 25; 41(7):427-30. PubMed ID: 4114830
    [No Abstract] [Full Text] [Related]

  • 17. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB.
    Eur J Respir Dis Suppl; 1983 Jul 25; 129():1-44. PubMed ID: 6418559
    [Abstract] [Full Text] [Related]

  • 18. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).
    Kay AB, Shin HS, Austen KF.
    Immunology; 1973 Jun 25; 24(6):969-76. PubMed ID: 4123965
    [Abstract] [Full Text] [Related]

  • 19. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
    Wasserman SI, Whitmer D, Geotzl EJ, Austen KF.
    Proc Soc Exp Biol Med; 1975 Jan 25; 148(1):301-6. PubMed ID: 1129271
    [Abstract] [Full Text] [Related]

  • 20. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM, König W, Lichtenstein LM.
    J Immunol; 1976 Jul 25; 117(1):229-34. PubMed ID: 778263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.